Condition: Thymoma · Sponsor: Fudan University
This study is designed to investigate whether adjuvant radiotherapy after complete resection has a better survival for stage II or III thymoma.
This description comes directly from the study's public registry record.
Kailiang Wu, MD.PhD. · +86 64175590 · wukailiang@aliyun.com
Xingwen Fan, MD · +8613651669687 · wenxingfan@126.com
Always discuss trial participation with your own doctor first.
| Kailiang Wu | Shanghai, Shanghai Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02633553